【賀】黃志揚副院長發表優秀論文於Cancers期刊(影響係數:6.162)

 

 恭賀範本 黃志揚

中文摘要 黃志揚

 

發表文章 2018 JCR Impact Factor & Ranking

FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer
(https://www.ncbi.nlm.nih.gov/pubmed/31623173)
【Cancers. 2019 Oct 16;11(10). pii: E1576.
    doi: 10.3390/cancers11101576.】

IF=6.162
Ranking=13.47%
(31/230 ONCOLOGY)